Give Online: Help shape patient care for generations to come.
Cleveland Clinic Logo


Request an Appointment

Cancer Answer Line:

M-F 8 a.m. - 4:30 p.m. ET

Expand Content

View Cancer Clinical Trials

CBMT 1Z11   |   CC00162
(Adult/Pediatric) A multicenter access and distribution protocol for unlicensed cryopreserved cord blood units (CBUs) for transplantation in pediatric and adult patients with hematologic malignancies and other indications

Blood & Marrow Transplant (BMT)
Hematologic Malignancy
Main Campus

Contact Information
Cancer Answer Line


8:00 am - 4:30 pm, Monday - Friday

  1. Primary Objective
    • The primary aim of this study is to examine the incidence of neutrophil recovery of ≥500/mm³ after cord blood transplantation in a multi-institution setting using CBUs that are not FDA licensed.
  2. Secondary Objectives (In patients receiving a non-licensed CBU):
    • Assess incidence of transmission of infection
    • Assess incidence of serious infusion reaction
    • Determine 1 year survival after cord blood transplantation
    • Assess cumulative incidence of acute GVHD grades II to IV and grades III to IV
    • Assess cumulative incidence of chronic GVHD
    • Determine platelet engraftment of >20,000 mcL and >50,000 mcL

Inclusion Criteria
  1. Disorders affecting the hematopoietic system that are inherited, acquired, or result from myeloablative treatment
  2. Signed informed consent (and signed assent, if applicable)
  3. Pediatric and adult patients of any age

Exclusion Criteria
  • Patients who are receiving only licensed CBUs
  • Cord blood transplant recipients at international transplant centers
  • Patients who are enrolled on another IND protocol to access the unlicensed CBU(s)
  • Patients whose selected unlicensed CBU(s) will be more than minimally manipulated

Cancer Answers & Appointments

Speak with a cancer nurse specialist for appointment assistance and for answers to your questions about cancer locally at 216.444.7923 or toll-free 1.866.223.8100.

Monday through Friday from 8 a.m. – 4:30 p.m. (ET).


Resources for medical professionals

  • Outpatient appointment referrals: 216.444.7923 or 866.223.8100
  • Inpatient hospital transfers: 800.553.5056
  • Referring Physician Concierge: 216.444.6196 or 216.312.4910.

Clinical Trials

Search available cancer clinical trials by disease, hospital, phase or number.